search
Back to results

Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery (SPECS)

Primary Purpose

Cancer of Colon, Cancer of Rectum, Liver Metastases

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Prehabilitation
Sponsored by
East Lancashire Hospitals NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cancer of Colon focused on measuring prehabilitation, surgery, cardiopulmonary exercise testing, cytokines

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Aged 18-85
  • Sex: male/female
  • Radiological/tissue cancer diagnosis
  • Curative cancer of the colon, rectum, colorectal liver metastases (CRLM) of 2 or more segments
  • elective surgery (planned a minimum of 3 weeks from the date of first clinic meeting)
  • Access to digital technology(mobile phone, tablet or laptop, home computer) to participate in supervised home exercise

Exclusion Criteria:

Exclusion

  • Palliative disease
  • Haematological malignancy
  • Pregnancy
  • Emergency surgery
  • Physically unable to undergo CPET
  • Part of any other trial with similar interventions unless previously agreed on with all CIs
  • synchronous disease (operation on HPB & colorectal cancers at the same operation)
  • No access to digital technology(smart phone, tablet, laptop or home computer)

Sites / Locations

  • Royal Blackburn Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Standard care

Prehabilitation

Arm Description

Standard Care: Surgery school as per ELHT pre-operative guidelines (includes generic pre-operative information, advice and optimisation e.g correction of anaemia)

Surgery School plus Moderate intensity exercise & Forceval (multivitamin)

Outcomes

Primary Outcome Measures

Anaerobic threshold (AT) measured in ml/kg/min and maximum oxygen consumption ( VO2 peak) measured in ml/kg/min
Cardiopulmonary exercise Test (CPET) variables
Inflammatory cytokines
IL6 IL10 in muscle and blood measured in pg/ml

Secondary Outcome Measures

Clavien-Dindo complication rates
Grades I-IV
Length of hospital stay measured in days
Defined as duration of stay from date of operation to discharge
Quality of life measures (Illness Perception Questionnaire)
This questionnaire assesses perceptions on each of the five dimensions(Identity, Cause, Timeline, Consequences, Cure-Control) by asking patients for their own beliefs about their condition. High scores on the identity, consequences, timeline acute/ chronic and cyclical subscales represent strongly held beliefs about the number of symptoms attributed, the negative consequences, and the chronicity and cyclical nature of the illness. High scores on the identity and cure-control and coherence subscales represent positive beliefs about controllability and a personal understanding of the illness.
Hand Grip Strength measured in kg
Measured by digital dynamometer
Quality of life measure (Mental Adjustment to Cancer Scale)
Assessment of participants mental adjustment to a cancer diagnosis. Designed to measure Fighting Spirit (FS), Anxious Preoccupation (AP), Helpless-hopelessness (HH) and Fatalism. This is a 40-item measure of specific psychological (Coping) responses that cancer patients may display in the process of adjusting to the diagnosis and treatment of their disease. A higher score represents higher endorsement of the adjustment response.

Full Information

First Posted
April 27, 2021
Last Updated
September 5, 2023
Sponsor
East Lancashire Hospitals NHS Trust
Collaborators
Lancaster University
search

1. Study Identification

Unique Protocol Identification Number
NCT04880772
Brief Title
Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery
Acronym
SPECS
Official Title
A Single-centre Two-armed Randomised Controlled Trial Comparing Standard Care Alone Versus Exercise and Nutrition Prehabilitation in Elective Patients Undergoing Resectional HPB and Colorectal Cancer Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
July 15, 2021 (Actual)
Primary Completion Date
July 13, 2023 (Actual)
Study Completion Date
July 13, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
East Lancashire Hospitals NHS Trust
Collaborators
Lancaster University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
To determine whether exercise and nutrition prehabilitation improves patient outcomes after cancer surgery
Detailed Description
Preliminary qualitative and quantitative studies suggest that there are benefits (reduced length of stay, improved cardiorespiratory function, reduced postoperative complications and improved quality of life) when prehabilitation is used with the context of cancer care. In 2017 Macmillian Cancer Support developed a strategic 'Evidence and Insight' review on prehabilitation. The outcome of this was to incorporate prehabilitation into routine cancer care and to develop principles and guidance for prehabilitation. This study aims to support this vision and answer some of the questions on the patients who are most likely to benefit from prehabilitation and to quantify some of these benefits by investigating the molecular processes that influence clinical changes This study primarily seeks to assess the cardiovascular and biological impact of prehabilitation (exercise, nutrition) on patients undergoing hepatobiliary and colorectal cancer surgery. The investigators aim to assess whether there is an improvement in various cardiopulmonary exercise testing (CPET) variables such as maximum oxygen consumption and anaerobic threshold. The investigators also aim to study the inflammatory cytokines associated with cancer and how these markers respond to exercise. These inflammatory markers are thought to play a role in influencing some clinical outcomes such as wound infection and recovery. The study will also assess secondary outcomes including hospital stay, post operative complications and quality of life. The investigators aim to better understand the biological relationship between anti-inflammatory cytokine levels and the previously mentioned outcomes by measuring and analysing these mediators and performing selected muscle biopsies.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cancer of Colon, Cancer of Rectum, Liver Metastases
Keywords
prehabilitation, surgery, cardiopulmonary exercise testing, cytokines

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
1:1 randomisation to standard care or prehabilitation
Masking
Outcomes Assessor
Masking Description
CPET clinician/physiologist will be blinded
Allocation
Randomized
Enrollment
42 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard care
Arm Type
No Intervention
Arm Description
Standard Care: Surgery school as per ELHT pre-operative guidelines (includes generic pre-operative information, advice and optimisation e.g correction of anaemia)
Arm Title
Prehabilitation
Arm Type
Experimental
Arm Description
Surgery School plus Moderate intensity exercise & Forceval (multivitamin)
Intervention Type
Other
Intervention Name(s)
Prehabilitation
Intervention Description
exercise & multivitamin (nutritional/dietary advice)
Primary Outcome Measure Information:
Title
Anaerobic threshold (AT) measured in ml/kg/min and maximum oxygen consumption ( VO2 peak) measured in ml/kg/min
Description
Cardiopulmonary exercise Test (CPET) variables
Time Frame
change in baseline AT & VO2 peak at 4 weeks
Title
Inflammatory cytokines
Description
IL6 IL10 in muscle and blood measured in pg/ml
Time Frame
change in baseline cytokines at 4 weeks
Secondary Outcome Measure Information:
Title
Clavien-Dindo complication rates
Description
Grades I-IV
Time Frame
Up to 30 days from the day of operation
Title
Length of hospital stay measured in days
Description
Defined as duration of stay from date of operation to discharge
Time Frame
30 & 90-day mortality
Title
Quality of life measures (Illness Perception Questionnaire)
Description
This questionnaire assesses perceptions on each of the five dimensions(Identity, Cause, Timeline, Consequences, Cure-Control) by asking patients for their own beliefs about their condition. High scores on the identity, consequences, timeline acute/ chronic and cyclical subscales represent strongly held beliefs about the number of symptoms attributed, the negative consequences, and the chronicity and cyclical nature of the illness. High scores on the identity and cure-control and coherence subscales represent positive beliefs about controllability and a personal understanding of the illness.
Time Frame
baseline and within 24 weeks after surgery
Title
Hand Grip Strength measured in kg
Description
Measured by digital dynamometer
Time Frame
baseline, immediately after the intervention, within 24 weeks after surgery
Title
Quality of life measure (Mental Adjustment to Cancer Scale)
Description
Assessment of participants mental adjustment to a cancer diagnosis. Designed to measure Fighting Spirit (FS), Anxious Preoccupation (AP), Helpless-hopelessness (HH) and Fatalism. This is a 40-item measure of specific psychological (Coping) responses that cancer patients may display in the process of adjusting to the diagnosis and treatment of their disease. A higher score represents higher endorsement of the adjustment response.
Time Frame
baseline and within 24 weeks after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged 18-85 Sex: male/female Radiological/tissue cancer diagnosis Curative cancer of the colon, rectum, colorectal liver metastases (CRLM) of 2 or more segments elective surgery (planned a minimum of 3 weeks from the date of first clinic meeting) Access to digital technology(mobile phone, tablet or laptop, home computer) to participate in supervised home exercise Exclusion Criteria: Exclusion Palliative disease Haematological malignancy Pregnancy Emergency surgery Physically unable to undergo CPET Part of any other trial with similar interventions unless previously agreed on with all CIs synchronous disease (operation on HPB & colorectal cancers at the same operation) No access to digital technology(smart phone, tablet, laptop or home computer)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joel Lambert
Organizational Affiliation
Senior Clinical Research Fellow
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Chris Gaffney
Organizational Affiliation
Lancaster University
Official's Role
Study Director
Facility Information:
Facility Name
Royal Blackburn Hospital
City
Blackburn
ZIP/Postal Code
BB@ 3HH
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Anonymised CPET data to be shared with other researchers. Anonymised tissue and blood samples to be shared with other researchers for analysis
IPD Sharing Time Frame
18 months
IPD Sharing Access Criteria
Full anonymisation
Citations:
PubMed Identifier
33201129
Citation
Lambert JE, Hayes LD, Keegan TJ, Subar DA, Gaffney CJ. The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-Accordant Meta-analysis. Ann Surg. 2021 Jul 1;274(1):70-77. doi: 10.1097/SLA.0000000000004527.
Results Reference
background
Links:
URL
http://www.surgicalbridges.co.uk
Description
study website

Learn more about this trial

Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery

We'll reach out to this number within 24 hrs